Back
Herc Holdings Vs. Blueprint Medicines Industry Stock Comparison
Sell
9
HRI
Herc Holdings
Last Price:
$122.32
Seasonality Move:
-11.86%
Sell
45
BPMC
Blueprint Medicines
Last Price:
$89.86
Seasonality Move:
4.39%
Sell
9
Herc Holdings (HRI)
is a Sell
Is Herc Holdings a Buy, Sell or Hold?
-
The current Herc Holdings [HRI] share price is $122.25. The Score for HRI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
HRI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $89.84. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRI Stock Price Chart
What is Herc Holdings's stock price today?
-
The Herc Holdings share price today is $122.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRI is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $89.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.
HRI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -19.21 | Sell |
Relative Strength Index (14 RSI): | 24.49 | Sell |
Chaikin Money Flow: | -172597 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.07 - 199.27) | Sell |
Bollinger Bands (100): | (167.95 - 224.13) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.53 | Sell |
Relative Strength Index (14 RSI): | 41.73 | Sell |
Chaikin Money Flow: | 267472 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.13 - 103.25) | Sell |
Bollinger Bands (100): | (87.18 - 104.18) | Sell |
HRI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.15 | Sell |
20-day SMA: | 156.99 | Sell |
50-day SMA: | 181.53 | Sell |
200-day SMA: | 169.12 | Sell |
8-day EMA: | 131.49 | Sell |
20-day EMA: | 150.72 | Sell |
50-day EMA: | 173.17 | Sell |
200-day EMA: | 173.48 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 89.11 | Buy |
20-day SMA: | 92.5 | Sell |
50-day SMA: | 98.88 | Sell |
200-day SMA: | 97.75 | Sell |
8-day EMA: | 89.85 | Sell |
20-day EMA: | 93.13 | Sell |
50-day EMA: | 96.36 | Sell |
200-day EMA: | 94.4 | Sell |
Herc Holdings Earnings Growth & HRI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $1.81 per share, a decrease this year of $0.22 per share, and an increase next year of $2.61 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $2.69 per share.
Herc Holdings Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |